GSA Capital Partners’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-13
| Closed | -$57K | – | 2013 |
|
|
2023
Q2 | $57K | Buy |
+13
| New | +$57K | 0.01% | 1417 |
|
|
2023
Q1 | – | Sell |
-27
| Closed | -$71K | – | 2012 |
|
|
2022
Q4 | $71K | Sell |
27
-9
| -25% | -$23.7K | 0.01% | 1334 |
|
|
2022
Q3 | $141K | Buy |
36
+29
| +414% | +$114K | 0.02% | 1309 |
|
|
2022
Q2 | $19K | Buy |
+7
| New | +$19K | ﹤0.01% | 1323 |
|
|
2021
Q4 | – | Sell |
-21
| Closed | -$195K | – | 1876 |
|
|
2021
Q3 | $195K | Buy |
+21
| New | +$195K | 0.02% | 1248 |
|
|
2021
Q1 | – | Sell |
-7
| Closed | -$40K | – | 1571 |
|
|
2020
Q4 | $40K | Hold |
7
| – | – | 0.01% | 1142 |
|
|
2020
Q3 | $26K | Buy |
+7
| New | +$26K | ﹤0.01% | 1211 |
|